Looking back at #EANM2025 in Barcelona!

Part of our team had the opportunity to attend this key congress for nuclear medicine, fostering valuable exchanges and opening new perspectives.

🧫 Preclinical
Discussions focused on the acquisition of a Micro SPECT by 2026, essential for preclinical therapeutic projects.

📝 Clinical Research
Our project leaders engaged with several industry partners, strengthening our position in early-phase clinical studies in Nancy and paving the way for new collaborations.

🧪 Radiochemistry
Meetings with LabLogic and Trasis led to progress on key projects, including equipment acquisition for alpha emitter detection submitted to the LUMIN call, and discussions continuing our collaboration on Cu-64.

EANM is all about networking and reconnecting, notably with Laurène Wagner, former PhD student at Nancyclotep, now pursuing her career at the Translational Radiotheranostics Unit in Heidelberg.

🗓️ See you in Vienna for #EANM2026!

A big thank you to the Nancyclotep team and the Nuclear Medicine Department at CHRU de Nancy for their commitment and energy.